Start the day here

AI — Trust — Anthropic

The Problem With Waiting for AI to Cure Cancer

Investor Gavin Baker told Anthropic CEO Dario Amodei to stop sounding so grim and start selling the upside. Amodei's Saturday reply on X refused the PR brief. The public's sour view of AI, he wrote, is older than any one executive's risk talk: ordinary people already expect companies and governments to invent a new way to screw them.

He named the cheap hope that fails. "Saying that AI will cure cancer is more a cliche than it is inspiring," Amodei wrote, "and most people think it is deceptive." Delivery is the only receipt he trusts. "The thing that will work is actually curing cancer."

7 min read
Open blister packs of blue, orange, and white capsules scattered across a white table
Dario Amodei@DarioAmodei

2/2 Second, on the messaging around AI. I do not agree that my messaging has been disproportionately negative. In fact it has been about equally balanced between risks and benefits: I've written one major essay about each, and even in interviews where I discuss the risks, I make sure to frequently mention the incredible benefits as well as proposing possible solutions to the risks (short clips from my interviews that end up on social media tend to be disproportionately negative, as that gets clicks). In fact, I wrote Machines of Loving Grace because I didn't feel the AI industry was painting an inspiring enough picture of how the technology could radically transform the world for the better. The bulk of the essay is devoted to refuting skepticism of AI's potential in health and biology, and showing why I think it will actually be possible to cure most human disease in ~5-10 years, as crazy as it may sound to ordinary people and frankly to biologists as well (I used to be one!). And, if you read my most recent essay (Policy on the AI Exponential), I discuss concrete proposals for how to streamline the FDA process to make sure the deluge of AI-accelerated drugs isn't slowed down by the regulatory process. I feel the urgency here: I lost my father to Hepatitis C only a few years before the development of direct-acting antivirals (sofosbuvir), which cure 95% of patients and probably would have cured him.

I do agree that the public has a negative view of AI (and that this is a big problem), but I don't think it is primarily caused by me or any other AI leader warning about AI's risks. I think it is fundamentally a crisis of trust. I think that ordinary people don't trust companies, governments, or the tech industry and always suspect that we are cooking up some new way to screw them over. The causes of this go back decades and AI is just the latest iteration of it. I don't think that a glitzy marketing campaign with a positive spin (which some have advocated that Anthropic do) is the way to win back that trust — at this point, saying that AI will cure cancer is more a cliche than it is inspiring, and most people think it is deceptive. The thing that will work is *actually curing cancer*. I think by far the most accurate criticism of AI companies including Anthropic is that we haven't yet delivered on our big promises to benefit the world. That is totally on us, and I think it's the criticism you should be making, instead of all this stuff about messaging and marketing.

We are however doing our best to fix this: Anthropic is ramping up its efforts very quickly in biology and medicine, and we hope to have incredible results in the coming years and some early glimmers in the coming months. When we've actually accomplished something real, the whole world will hear about it, as loudly as possible, you have my word on that. But until then I don't want to make empty promises, and in the meantime I feel compelled to speak honestly about the very real risks of AI and how to address them. Honesty is the right thing on the merits, and in terms of public credibility and trust it is no worse than, and may in fact be better than, an approach that ignores or distracts from risks which people instinctively understand are real.

Delivery, deferred

The self-indictment is clearer than the timeline. Amodei said the fairest criticism of AI companies, Anthropic included, is that they have not yet delivered on big promises to benefit the world. He pointed to Anthropic's biology and medicine push, with "early glimmers" hoped for in months and louder results later. TechCrunch carried the exchange on August 16. Baker had framed Amodei's warnings as fuel for data-center backlash; Amodei answered with decades of eroded institutional trust.

He also rejected a Silicon Valley shorthand that treats regulation as capture by default. In his telling, AI already concentrates power through scale, and open weights only shift that concentration toward whoever holds the most compute. The "rules of the road" he wants would hit cyber, bio, and alignment risks, constrain frontier labs, and still leave room for open models under scrutiny. House Democrats, in the same news cycle, were pressing Speaker Mike Johnson to put AI CEOs under oath over recent cyber spills. Messaging was never the only theater.

The wrong clock

Amodei is right that empty oncology slogans sound like a con. He is less convincing when he makes a future cure the primary solvent for present distrust. Neighbors fighting data centers, workers watching agents fail containment tests, and users watching tools migrate behind enterprise badges are not waiting for a Phase III readout. They are scoring the industry on the systems it ships now. Even Anthropic's bio filters missed contractor traffic at industrial scale; that is the kind of ledger people already keep.

Curing cancer would be an extraordinary public good. It would not automatically repay the trust debt Amodei described, any more than a miracle drug would excuse an opaque welfare algorithm or a model that wanders into someone else's production cluster. Treat medical breakthroughs as medical breakthroughs. Earn institutional trust on the shorter clock of power, spill, and who gets locked out while the lab waits for the headline.

Live scoreboardFollow the AI race on AI Wars

Lab rankings, model preference, API volume, coding-agent heat, open-source stars, and prediction markets.

Related stories

Two hands write with a mechanical pen across a stack of white papers on a dark deskAcute Social Issues

Judge Lin Vacated Anthropic's Supply-Chain Risk Label

Today

A dark wooden gavel with a brass band resting on its sound blockAcute Social Issues

Is AI Consciousness Just a Liability Shield?

Today

Red candlestick chart sloping downward on a dark trading screenAcute Social Issues

DeepMind Measured How Gemini Steers Beliefs and Money

Today

Letters

0

No letters yet.

Write a letter